Understanding genetic factors contributing to lung cancer risk is a growing focus within medical research. Recent groundbreaking findings have identified a rare inherited mutation that can increase an individual’s likelihood of developing lung cancer by approximately 25 times overall, and by about 60 times among those who have never smoked, as detailed in a study published in the journal Science. The research, carried out by researchers at the Dana-Farber Cancer Institute and the 23andMe Research Institute, analyzed anonymized genetic data from over 3.3 million individuals. They pinpointed the germline variation, known as EGFR T790M, as one of the most potent inherited risk factors for lung cancer identified to date.

India’s drug regulatory authority has issued a warning to the public regarding two skincare products originating from Pakistan after tests revealed high levels of heavy metals. The Central Drugs Standard Control Organisation issued a public health alert on September 8, citing Goree Beauty Cream and Chandni Whitening Cream. Both items are labeled as manufactured in Pakistan. The agency confirmed that neither product holds authorization for import or sale within India, and warned that the presence of excessive heavy metals could lead to toxic effects and health hazards.

The World Health Organization reports that Ebola transmission is decreasing in some of the hardest-hit regions of the Democratic Republic of the Congo. This positive trend is most evident in parts of Ituri province, which has been the central focus of the outbreak. Nevertheless, the epidemic persists and continues to expand in other areas. According to official data through Sept. 13, there have been 7,258 confirmed cases and 3,510 deaths across seven provinces, with the overall case fatality ratio at 48.4%.

NEW YORK / RankWire.AI / – As part of the ongoing investigation into a Legionnaires’ disease outbreak in the South Bronx, initial tests have identified Legionella DNA in a cooling tower located at Yankee Stadium. The City of New York is actively examining a cluster of Legionnaires’ disease cases. By Tuesday night, authorities confirmed 11 infections, including one fatality. Three individuals remain hospitalized. The New York City Health Department has pinpointed 10 cooling towers with preliminary positive PCR results across ZIP codes 10451 and 10456, covering parts of Melrose and Morrisania.

Funding and Staffing Challenges Limit Ebola Response Efforts in Congolese Regions A key obstacle is the shortage of non-governmental partners capable of managing complex isolation facilities. World Health Organization technical expert Luca Fontana pointed out that just five or six international humanitarian organizations have the expertise needed to establish and operate specialized Ebola treatment centers. Without additional operational partners stepping in to oversee established sites, technical teams remain tied to existing facilities, limiting their ability to deploy resources to new outbreak hotspots. In response, the Ministry of Health of the Congo has taken direct control over several treatment centers set up during the early stages of the epidemic. However, officials caution that the country’s capacity to manage these facilities is limited.

The World Health Organization has emphasized the need for an extensive expansion of the Ebola response within the Democratic Republic of the Congo. According to Director-General Tedros Adhanom Ghebreyesus, health teams have yet to trace every chain of transmission. As of Sept. 1, government reports confirmed 6,250 cases and 3,039 fatalities in Congo. The ongoing Bundibugyo Ebola outbreak now spans 60 health zones across six provinces. Congo’s Ebola response expands as Bundibugyo transmission remains active. This outbreak has become Congo’s most extensive and deadliest Ebola event to date.

Health authorities in the Democratic Republic of the Congo have launched a targeted Ebola vaccination initiative in Kisangani, the administrative center of Tshopo Province, to combat what is now the country’s most severe outbreak on record. Frontline healthcare workers, emergency response personnel, and individuals who have had direct contact with confirmed cases are being prioritized during the initial phase of the deployment.

In response to the escalating Ebola situation, the European Commission has committed €2.1 million to acquire PCR testing kits specifically for the ongoing Bundibugyo Ebola outbreak. These open-platform tests aim to enhance detection efforts and bolster laboratory capacities during the crisis. The procurement was coordinated with support from the European Health and Digital Executive Agency, with delivery schedules starting in August to supplement diagnostic supplies as health authorities combat increasing case numbers in the Democratic Republic of the Congo.

DR Congo expands its Ebola response as Bundibugyo cases spread across six provinces. Following the government’s appeal for assistance from the global Ebola stockpile, the International Coordinating Group on Vaccine Provision authorized the release of vaccines. WHO indicated that 20,000 doses will be used in a Phase 3 clinical trial targeting Bundibugyo virus disease. The remaining 50,000 doses will be allocated to frontline health workers and medical personnel, in line with current vaccination policies. Both WHO and Africa CDC welcomed this decision, announced on Aug. 20.

WHO incident manager, Thierno Baldé, stated that the projected three-month containment of the Ebola outbreak in Congo depends heavily on acquiring the necessary resources. The agency has secured approximately $69.3 million out of the $115 million needed, which is roughly 60%. Over the past two weeks, teams have added more than 400 treatment beds and deployed 100 extra epidemiologists along with over 500 community health workers to bolster surveillance and contact tracing efforts. The response efforts also require transportation vehicles, ambulances, medical supplies, and personnel to cover the expanding impacted regions.